Motohiko Adomi

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Patients With Inflammatory Bowel Disease

Cross Sectional

Coronavirus Disease

Top Venues

Journal of clinical medicine

Journal of the American Geriatrics Society

Alimentary pharmacology & therapeutics

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Motohiko Adomi, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
Comparative risk of fracture in community-dwelling older adults initiating suvorexant versus Z-drugs: results from LIFE study. Journal of the American Geriatrics Society (2022)
Motohiko Adomi, Toshiki Kuno, Jun Komiyama, Yuta Taniguchi, Toshikazu Abe, Atsushi Miyawaki, Shinobu Imai, Kojiro Morita, Makoto Saito, Hiroyuki Ohbe, Tadashi Kamio, Nanako Tamiya, Masao Iwagami
Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan. Pharmacoepidemiology and drug safety 31 (6) (2022)
Motohiko Adomi, Avik Ray
Letter: potential selection bias in the real-world comparison of ustekinumab versus vedolizumab as a second-line treatment for Crohn's disease. Alimentary pharmacology & therapeutics 55 (8) (2022)
Ryota Inokuchi, Toshiki Kuno, Jun Komiyama, Kazuaki Uda, Yoshihisa Miyamoto, Yuta Taniguchi, Toshikazu Abe, Miho Ishimaru, Motohiko Adomi, Nanako Tamiya, Masao Iwagami
Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study. Journal of clinical medicine 11 (1) (2021)